Dana-Farber’s Largest Single Gift Advances Planned Cancer Hospital for New England
Temple Health Appoints Alex Khariton, MBA, as Chief Operating Officer of Fox Chase Cancer Center
Three Dana-Farber Cancer Institute scientific leaders elected as Fellows of the American Association for Cancer Research (AACR) Academy Class of 2026
Taming Chronic Inflammation
Ten Cancer-Related Breakthroughs Giving Us Hope in 2026
More Than 145 Dana-Farber Affiliated Faculty Named as 2026 Top Doctors™ in Boston Magazine
ADC Combination Outperforms Standard Treatment of Advanced Triple-Negative Breast Cancer
Dana-Farber Researchers Create Experimental AI-based Oncologist’s Assistant
Dr. Mariella Filbin Receives 2026 Emerging Leader Award from The Mark Foundation
Study Finds Radiation Therapy Administered Before Surgery Rarely Shrinks Retroperitoneal Sarcoma Tumors
Seeing Is Believing
Home-Based Monitoring Could Transform Care for Patients Receiving T-Cell Redirecting Therapies
Dana-Farber Researchers Discover How Major Nuclear Protein Complexes Control Specialized Gene Regulation in Cancer and Beyond
Twenty-Five Years of Progress in Cancer
Dana-Farber Cancer Institute and Dana-Farber/Boston Children’s Cancer and Blood Disorders Center recognized for exceptional outcomes in donor stem cell transplants
Showing 16 - 30 of 1016 results
Previous| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 ...68 |Next
Cancer
Cardiology
Gastroenterology
Neurology
OBGYN
Orthopedics
Pediatrics
BroadcastMed News
Dermatology
Diabetes & Endocrinology
Infectious Diseases
Ophthalmology
Optometry
Otolaryngology
Pulmonology
Surgery
Urology
About
Solutions
Resources
Contact
person Sign In / Create Account
